Single cell Transcriptome-based developmental trajectories reveal developmental abnormalities in glaucoma patient-specific RGCs. A comparison of the developmental trajectories, based on lineage- and ...
A phase 3, randomized, open-label study of the anti-Globo H vaccine adagloxad simolenin/obi-821 in the adjuvant treatment of high-risk, early-stage, Globo H-positive triple-negative breast cancer.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc (VCYT). (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that eight abstracts featuring data derived from testing with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback